Journal
ELIFE
Volume 10, Issue -, Pages -Publisher
ELIFE SCIENCES PUBLICATIONS LTD
DOI: 10.7554/eLife.66835
Keywords
-
Categories
Funding
- American Diabetes Association [1-19-PDF-099]
- China Scholarship Council [201908420207]
- National Institute of Diabetes and Digestive and Kidney Diseases [DK104999, DK056731]
- Molecular Genetics Core [P30 DK020572]
Ask authors/readers for more resources
A sensitive dual recombinase-activated viral approach, tTARGIT, was developed to manipulate neural populations precisely, addressing the issue of reduced efficacy when using Cre and Flp recombinases.
While Cre-dependent viral systems permit the manipulation of many neuron types, some cell populations cannot be targeted by a single DNA recombinase. Although the combined use of Flp and Cre recombinases can overcome this limitation, insufficient recombinase activity can reduce the efficacy of existing Cre+Flp-dependent viral systems. We developed a sensitive dual recombinase-activated viral approach: tTA-driven Recombinase-Guided Intersectional Targeting (tTARGIT) adeno-associated viruses (AAVs). tTARGIT AAVs utilize a Flp-dependent tetracycline transactivator (tTA) 'Driver' AAV and a tetracycline response element-driven, Cre-dependent 'Payload' AAV to express the transgene of interest. We employed this system in Slc17a6(FlpO); Lepr(Cre) mice to manipulate LepRb neurons of the ventromedial hypothalamus (VMH; LepRb(VMH) neurons) while omitting neighboring LepRb populations. We defined the circuitry of LepRbVMH neurons and roles for these cells in the control of food intake and energy expenditure. Thus, the tTARGIT system mediates robust recombinase-sensitive transgene expression, permitting the precise manipulation of previously intractable neural populations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available